vaccin
import
control
prevent
diseas
newli
gener
current
develop
vaccin
highli
purifi
recombin
antigen
higher
safeti
purifi
antigen
stimul
satisfactori
immun
respons
compar
attenu
inactiv
pathogen
prepar
aid
adjuv
vaccin
induc
persist
immun
respons
new
power
adjuv
wide
concern
vaccin
develop
human
health
date
variou
adjuv
identifi
extens
studi
adjuv
endow
vaccin
sever
advantag
includ
decreas
requir
amount
antigen
minim
number
immun
requir
normal
immun
respons
induc
rapid
broader
stronger
immun
respons
although
mani
potent
adjuv
develop
lipolysaccharid
lp
freund
complet
adjuv
fca
wide
appli
due
toxic
henc
adjuv
alum
licens
clinic
use
overal
effect
safer
adjuv
develop
promot
better
prophylact
therapeut
vaccin
infecti
noninfecti
diseas
safeti
import
consider
factor
develop
adjuv
chines
herbac
constitu
includ
nutrient
import
activ
composit
phenol
compound
polysaccharid
act
power
immunostimul
among
polysaccharid
tradit
chines
herb
wide
explor
due
immunostimulatori
activ
low
toxic
exampl
inulin
immun
adjuv
without
toxic
adjuv
fca
advaxtm
delta
inulin
adjuv
also
success
enhanc
immunogen
vaccin
astragalu
also
known
huangqi
chines
radix
astragali
latin
wide
distribut
throughout
world
polysaccharid
one
major
activ
ingredi
respons
immunomodulatori
activ
experiment
studi
demonstr
astragalu
polysaccharid
possess
strong
immunomodulatori
effect
vitro
vivo
lycium
barbarum
polysaccharid
vaccin
adjuv
also
show
good
improv
stimul
effect
studi
suggest
chines
herbral
polysaccharid
ideal
candid
adjuv
develop
cistanch
deserticola
c
cd
rou
cong
rong
chines
valuabl
tradit
chines
herb
commonli
consid
ginseng
desert
superior
tonic
effect
distribut
arid
semiarid
region
xinjiang
china
dri
fleshi
stem
use
tonic
food
hundr
year
mani
year
boil
cd
use
tonic
food
treat
overstraininduc
impair
suggest
safe
oral
administr
plant
wide
concern
due
broad
medicin
function
recent
phytochem
pharmacolog
studi
demonstr
polysaccharid
main
biolog
activ
compon
variou
biolog
effect
includ
immunomodulatori
activ
antioxid
effect
antiinflammatori
effect
howev
immun
enhanc
activ
waterextract
polysaccharid
c
deserticola
xinjiang
seldom
report
well
known
dc
import
antigen
present
cell
apc
provid
signal
requir
initi
immun
respons
modul
innat
adapt
cell
adjuv
improv
antigen
uptak
dc
increas
costimulatori
mhc
molecul
enhanc
immun
dc
matur
start
costimulatori
molecul
cytokin
produc
dc
show
distinct
phenotyp
studi
firstli
exploit
whether
wpcd
could
promot
activ
dc
via
signal
pathway
vivo
sinc
dc
link
innat
adapt
immun
respons
hypothes
dc
activ
stimul
wpcd
would
influenc
outcom
adapt
immun
examin
specif
immun
respons
ovalbumin
ova
mice
treat
wpcd
includ
titer
igg
subclass
b
prolifer
product
cytokin
investig
whether
wpcd
treatment
would
increas
activ
dc
treg
cell
spleen
mice
find
prove
potenti
immunomodulatori
activ
natur
polysaccharid
c
deserticola
expand
applic
scope
eight
tenweek
old
balbc
icr
femal
mice
purchas
first
hospit
xinjiang
medic
univers
urimuqi
xinjiang
china
mice
hous
pathogenfre
condit
accord
guidelin
anim
care
use
committe
acuc
xinjiang
univers
anim
health
wellb
anim
experi
procedur
approv
aucc
xinjiang
univers
c
deserticola
plant
xinjiang
provinc
china
crude
polysaccharid
obtain
water
extract
ethanol
precipit
briefli
g
dri
c
deserticola
ground
powder
filter
powder
reflux
petroleum
ether
room
temperatur
repeatedli
reflux
anhydr
ethanol
h
remov
color
ingredi
lipid
residu
extract
boil
water
three
time
extract
pool
togeth
centrifug
rpm
min
reflux
h
four
time
volum
ethanol
ad
solut
order
precipit
crude
polysaccharid
crude
polysaccharid
redissolv
distil
water
treat
sevag
reagent
remov
protein
extract
dissolv
pb
steril
filter
final
total
sugar
content
wpcd
indic
acid
analysi
bmdc
gener
accord
previous
describ
method
slightli
modif
bone
marrow
dc
mice
flush
complet
medium
gibco
supplement
fetal
calf
serum
hyclon
collect
cell
resuspend
medium
sigma
st
loui
mo
ngml
murin
gmcsf
peprotech
rocki
hill
ny
incub
atmospher
half
cultur
medium
replac
fresh
medium
contain
gmcsf
everi
day
cell
collect
day
treat
differ
dose
wpcd
lp
ngml
sigma
st
loui
mo
h
assess
flow
cytometri
vitro
matur
effect
wpcd
bmdc
evalu
base
phenotyp
analysi
result
fac
day
induc
presenc
gmcsf
treat
differ
concentr
wpcd
mgml
h
triplic
lp
ngml
use
posit
control
bmdc
wash
pb
fc
block
bd
bioscienc
ca
use
prevent
nonspecif
antibodi
bind
cell
stain
pb
use
appropri
fitc
pe
apcconjug
mhcii
antibodi
bd
min
stain
cell
detect
fac
calibur
bd
data
analysi
carri
flowjo
softwar
tree
star
dc
matur
experi
vitro
cell
cultur
supernat
also
collect
analyz
use
cytokin
assay
kit
boster
wuhan
china
accord
manufactur
instruct
absorb
nm
measur
elisa
plate
reader
biorad
usa
cytokin
quantiti
sampl
calcul
standard
curv
recombin
cytokin
accord
regress
linear
method
test
allogen
stimulatori
activ
experi
mix
lymphocyt
reaction
mlr
perform
accord
previou
method
mtt
sigma
st
loui
mo
assay
briefli
bmdc
mice
use
stimul
cell
recov
day
medium
plu
gmcsf
treat
variou
concentr
wpcd
h
cell
wash
resuspend
medium
plate
plate
singleplenocyt
suspensiona
respond
cell
isol
balbc
mice
bmdc
mix
splenocyt
accord
ratio
cell
cultur
atmospher
three
day
triplic
lp
treatment
use
posit
control
cultur
subsequ
ad
mtt
final
cultiv
absorb
measur
wavelength
nm
refer
wavelength
nm
measur
cell
prolifer
analysi
sampl
measur
background
control
bmdc
pretreat
inhibitor
medchemexpress
inc
usa
h
cocultur
variou
concentr
wpcd
h
presenc
absenc
golgi
stop
triplic
posit
control
lp
ad
cell
supernat
detect
fac
analyz
surfac
marker
elisa
analyz
cytokin
tnfa
respect
oral
acut
toxic
test
studi
healthi
adult
icr
mice
use
icr
mice
fast
food
water
overnight
dose
wpcd
oral
administ
respect
dose
mgkg
bodi
weight
anim
day
salinetr
alumtr
mice
includ
control
group
anim
observ
daili
within
consecut
day
mice
individu
observ
record
mortal
clinic
sign
addit
bodi
weight
food
water
consumpt
measur
throughout
experi
day
spleen
thymu
index
calcul
spleen
thymu
weightbodyweight
investig
whether
wpcd
immunomodulatori
activ
ovalbumin
ova
sigma
use
model
antigen
femal
icr
mice
randomli
separ
group
neg
control
group
nacl
wpcd
posit
control
alum
ova
mice
administ
subcutan
twice
ova
alon
wpcd
ova
accord
dose
interv
blood
sampl
spleen
obtain
booster
vaccin
order
detect
igg
titer
igg
subclass
splenocyt
prolifer
cytokin
dc
surfac
marker
treg
frequenc
ovaspecif
igg
titer
subclass
examin
elisa
accord
previou
method
elisa
plate
nunc
thermo
fisher
scientif
coat
overnight
block
serum
sampl
dilut
serial
igg
titer
analysi
detect
southern
biotech
inc
plate
incub
pbst
contain
hrpconjug
antimous
igg
h
colorimetr
reaction
develop
tetramethylbenzidin
tmb
absorb
nm
measur
express
optic
densiti
od
unit
splenocyt
prolifer
determin
mtt
assay
day
first
vaccin
singl
splenocyt
suspens
obtain
cell
cultur
medium
plate
accord
concentr
cellswel
triplic
cultur
stimul
ova
final
concentr
cona
final
concentr
sigma
st
loui
mo
lp
final
concentr
ngml
h
cell
cultur
h
mgml
mtt
sigma
st
loui
mo
ad
well
incub
anoth
h
ad
dmso
well
stop
color
develop
sigma
plate
read
nm
microtit
plate
reader
biorad
ca
usa
splenocyt
prolifer
express
stimul
index
si
nm
ratio
stimul
well
unstimul
well
yield
cell
measur
intracellular
cytokin
stain
accord
publish
protocol
minor
modif
singl
splenocyt
suspens
prepar
day
first
vaccin
red
blood
cell
lysi
splenocyt
cellsml
incub
ova
stimul
golgi
stop
bd
ad
h
incub
pma
posit
control
cell
collect
wash
pb
stain
fix
permeabil
cytofixcytoperm
kit
bd
accord
manufactur
instruct
intracellular
cytokin
stain
perform
appropri
concentr
antibodi
min
stain
cell
detect
fac
data
analysi
carri
flowjo
analysi
dc
matur
splenocyt
mice
cell
surfac
stain
perform
antibodi
day
first
vaccin
singl
splenocyt
suspens
cellsml
obtain
cell
subject
doubl
stain
fluoresc
intens
measur
fac
calibur
measur
data
analyz
flowjo
order
observ
whether
wpcd
could
downregul
frequenc
treg
cell
singl
splenocyt
suspens
prepar
day
second
vaccin
splenocyt
cellsml
subject
cell
surfac
stain
antibodi
follow
nuclear
cytokin
stain
appropri
antibodi
mous
regulatori
tcell
stain
kit
ebiosci
accord
manufactur
instruct
frequenc
treg
cell
test
fac
data
analysi
carri
flowjo
oneway
analysi
varianc
anova
test
tukey
multiplecomparison
test
perform
analyz
differ
among
multipl
experiment
group
valu
express
mean
p
believ
statist
signific
statist
analys
perform
use
prism
softwar
adapt
immun
determin
activ
dc
includ
type
costimulatori
molecul
cytokin
initi
investig
whether
wpcd
could
promot
express
costimulatori
molecul
accord
differ
dose
wpcd
bmdc
administ
express
level
mhcii
cell
analyz
fig
cell
gate
ssc
fsc
show
treatment
differ
dose
wpcd
chang
morpholog
bmdc
data
shown
express
level
significantli
upregul
dosedepend
manner
compar
untreat
group
reach
plateau
dose
wpcd
differ
signific
compar
lp
group
fig
express
level
mhcii
significantli
increas
maximum
valu
dose
fig
analysi
result
cellular
surfac
marker
demonstr
dc
treat
lp
wpcd
show
significantli
increas
express
level
mhcii
promot
phenotyp
matur
adjuv
could
increas
costimulatori
molecul
dc
directli
induc
secret
cytokin
major
cytokin
activ
immun
respons
analyz
yield
cytokin
upon
wpcd
treatment
treat
differ
content
wpcd
h
supernat
collect
detect
content
elisa
kit
wpcd
could
dosedepend
increas
product
fig
fig
result
demonstr
wpcd
could
induc
function
matur
dc
immun
respons
necessari
function
activ
dc
higher
level
allogen
cell
prolifer
induc
fulli
matur
dc
therefor
function
respons
dc
wpcd
investig
mlr
allostimulatori
capabl
wpcdinduc
dc
similar
lp
enhanc
dramat
dosedepend
manner
indic
ratio
fig
result
indic
wpcd
improv
antigen
present
optim
tcell
respons
mlr
vitro
could
infer
result
bmdc
activ
wpcd
indic
similar
dc
surfac
molecul
express
lp
ligand
thu
hypothes
bmdc
activ
wpcd
via
pathway
bmdc
pretreat
inhibitor
cocultur
wpcd
lp
h
express
tnfa
detect
fac
elisa
shown
fig
treatment
result
significantli
downregul
express
induc
lp
wpcd
cytokin
product
tnfa
also
significantli
decreas
fig
result
indic
wpcd
could
activ
dc
matur
pathway
purpos
comparison
evalu
effect
wpcd
elicit
humor
immun
respons
ovaimmun
mice
vaccin
day
first
vaccin
blood
collect
detect
igg
titer
igg
subclass
serum
elisa
igg
antibodi
respons
ova
increas
increas
dose
wpcd
administr
dosedepend
manner
fig
optim
concentr
wpcd
increas
igg
respons
two
time
compar
ova
alon
day
fig
consider
increas
ovaspecif
antibodi
level
wpcd
administr
obtain
compar
ova
group
serum
day
fig
meanwhil
alum
promot
express
level
ovaspecif
igg
antibodi
immun
mice
wpcd
alon
trigger
ovaspecif
antibodi
result
obvious
indic
wpcd
gener
higher
antibodi
titer
balanc
respons
alum
splenocyt
prolifer
anoth
indic
cellular
immun
cona
stimul
tcell
lp
stimul
bcell
prolifer
day
first
vaccin
singl
splenocyt
suspens
obtain
respect
stimul
ova
peptid
cona
lp
h
prolifer
cell
measur
mtt
method
wpcd
could
significantli
promot
ovaantigen
con
amitogen
lp
mitogenstimul
splenocyt
prolifer
mice
immun
ova
wpcd
fig
optim
concentr
wpcd
data
indic
wpcd
vaccin
adjuv
ovaimmun
mice
could
effect
induc
activ
tcell
b
cell
alum
test
wcpd
adjuv
formul
ova
vaccin
gener
equal
strong
humor
cellular
immun
fig
basi
data
evalu
wpcd
influenc
ovaspecif
helper
th
cell
respons
analyz
cytokin
express
cell
flow
cytometri
fig
day
first
vaccin
singl
splenocyt
mice
isol
cocultur
ova
yield
cell
group
administ
ovawpcd
significantli
higher
ovaalum
group
ova
group
similar
pma
fig
moreov
yield
cell
also
significantli
enhanc
mice
administ
ovawpcd
fig
compar
alum
adjuv
wpcd
show
better
capabl
induc
secret
cell
dc
recogn
potent
apc
involv
initi
primari
immun
respons
thu
day
first
vaccin
also
investig
effect
wpcd
dc
spleen
mice
fig
mice
ovawpcd
group
produc
significantli
higher
level
dc
ovaalum
group
data
show
wpcd
could
activ
dc
induc
dc
matur
mice
treg
cell
balanc
toler
immun
respons
investig
wpcd
modul
immun
respons
treg
cell
spleen
mice
stain
mous
regulatori
cell
stain
kit
day
first
vaccin
decreas
frequenc
treg
cell
observ
total
cell
fig
compar
ova
ovaalum
group
wpcd
group
show
significantli
reduc
treg
frequenc
order
estim
oral
acut
toxic
carri
acut
toxic
test
mice
oral
administ
mgkg
bodi
weight
show
abnorm
behavior
side
effect
mortal
found
toxic
evalu
test
signific
differ
bodi
weight
gain
thymu
index
spleen
index
record
among
variou
group
mice
administ
differ
dose
wpcd
signific
differ
tabl
mortal
observ
day
therefor
valu
wpcd
mg
per
kg
bodi
weight
test
whether
wpcd
neg
effect
growth
mice
subcutan
vaccin
bodi
weight
respect
determin
mous
tabl
subsequ
observ
mice
side
effect
abnorm
behavior
observ
besid
bodi
weight
mice
administ
wpcd
mice
administ
salin
solut
ovaalum
show
signific
differ
observ
result
demonstr
administr
wpcd
safe
adjuv
key
compon
vaccin
due
advanc
genom
proteom
recombin
synthet
vaccin
molecul
identifi
therefor
adjuv
formul
requir
potent
adjuv
gener
relat
increas
toxic
exampl
fca
therefor
necessari
find
safe
formul
contain
differ
synergist
compon
eventu
drive
desir
immun
respons
polysaccharid
chines
herb
nontox
show
signific
side
effect
safe
adjuv
requir
certain
vaccin
cistanch
deserticola
import
tonic
herb
wide
exist
arid
land
warm
desert
northwest
china
cistanch
deserticola
wide
concern
due
bioactiv
includ
immunomodulatori
antioxid
antibacteri
antitumor
effect
progress
made
structur
character
immunolog
activ
cistanch
deserticola
good
candid
develop
adjuv
experiment
evalu
adjuv
effect
mechan
wpcd
vitro
vivo
subcutan
administr
wpcd
significantli
promot
humor
cellular
immun
respons
increas
serum
antibodi
lymphocyt
prolifer
enhanc
express
cytokin
upregul
dc
matur
downregul
frequenc
treg
cell
dc
key
apc
prime
naiv
cell
activ
dc
import
adjuv
dc
especi
murin
marrowderiv
dc
often
use
evalu
adjuv
vaccin
flow
cytometri
distinguish
cell
activ
captur
antigen
surround
cell
fcm
analysi
degre
aggreg
stimul
cell
indirect
indic
evalu
safeti
immunomodul
thu
wpcd
adjuv
activ
data
dc
vitro
may
provid
valuabl
inform
anim
model
base
bmdc
model
express
level
mhcii
cytokin
product
allogen
cell
prolifer
detect
optimum
wpcd
concentr
rang
express
level
mhcii
upregul
bmdc
yield
tnfa
increas
dosedepend
manner
allogen
cell
prolifer
observ
morpholog
bmdc
chang
induc
bmdc
activ
secret
inflammatori
cytokin
vitro
wpcd
adjuv
might
significantli
increas
amount
antigen
amount
apc
stimul
cell
secret
contribut
enhanc
immunomodulatori
activ
variou
chines
herbac
polysaccharid
capabl
activ
immun
system
possess
excel
adjuv
abil
stimul
dc
matur
pathway
thu
assum
particip
signal
pathway
wpcdinduc
dc
matur
expect
inhibitor
treatment
result
signific
decreas
tnfa
furthermor
inhibit
pathway
also
hinder
express
cd
dc
indic
matur
dc
depend
therefor
obviou
particip
wpcdinduc
dc
matur
optimum
dose
adjuv
vaccin
formul
empir
determin
mani
experi
order
explor
doserespons
relationship
wpcd
adjuv
ova
antigen
mice
select
differ
wpcd
dose
base
previous
report
data
bmdc
vitro
subcutan
administ
icr
mice
twice
found
wpcd
significantli
increas
yield
ovaspecif
antibodi
induc
balanc
immun
respons
enhanc
level
especi
level
higher
treat
alum
optimum
dose
therefor
wpcd
result
higher
level
specif
antibodi
higher
efficaci
lower
inject
new
vaccin
requir
induct
strong
cellular
respons
involv
antibodi
helper
th
cell
cytotox
lymphocyt
ctl
therapeut
vaccin
aim
induc
stronger
cell
respons
ideal
adjuv
enhanc
potenc
vaccin
promot
cellmedi
immun
without
caus
toxic
effect
among
observ
immun
mice
model
wpcd
led
increas
ovaspecif
nonspecif
splenocyt
prolifer
compar
alum
adjuv
upregul
cytokin
immun
system
exampl
saponin
may
stimul
cellmedi
immun
respons
antigen
normal
induc
antibodi
select
indic
indirectli
evalu
level
immun
mice
wpcd
could
induc
secret
alum
thu
strong
helper
tcell
respons
cytokin
secret
observ
result
wpcd
vaccin
suggest
wpcd
could
effici
stimul
lymphocyt
secret
cytokin
cytokin
alum
adjuv
influenc
antigen
present
affect
complex
immun
process
treg
cell
modul
respons
appropri
dose
wpcd
may
promot
matur
dc
mice
via
increas
express
level
amplifi
capabl
ova
antigen
present
earli
immun
respons
experiment
result
dc
activ
treg
frequenc
demonstr
wpcd
induc
matur
dc
decreas
treg
frequenc
spleen
mice
result
prove
wpcd
enhanc
efficaci
ova
vaccin
increas
target
antigenpres
cell
promot
tcell
specif
activ
develop
adjuv
difficult
select
induc
appropri
immun
respons
correspond
infect
suitabl
adjuv
low
side
effect
toxic
human
be
anim
thu
wpcd
safeti
consid
includ
immedi
longterm
side
effect
studi
explor
acut
toxic
wpcd
neg
effect
wpcd
growth
perform
mice
day
result
acut
toxic
wpcd
show
bodi
weight
thymu
index
spleen
index
signific
differ
valu
wpcd
mg
per
kg
bodi
weight
throughout
experiment
subsequ
observ
mice
side
effect
abnorm
behavior
mice
found
result
indic
wpcd
safe
conclus
studi
wpcd
crude
polysaccharid
extract
c
deserticola
xinjiang
exhibit
properti
adjuv
exampl
wpcd
enhanc
respons
activ
dc
increas
antibodi
respons
improv
cytokin
product
moreov
explor
mechan
wpcd
efficaci
analyz
dc
matur
function
via
pathway
vitro
mice
treat
wpcd
obviou
side
effect
observ
henc
wpcd
possess
higher
immunostimulatori
activ
cellular
humor
immun
respons
adjuv
mixtur
sever
compound
mixtur
sever
crude
extract
may
greater
benefici
effect
singl
plant
extract
necessari
systemat
explor
wpcd
extract
test
efficaci
safeti
elucid
mechan
effect
